Study of P-glycoprotein Modulators in Cancer Treatment
Author Information
Author(s): Gadhe Changdev G, Madhavan Thirumurthy, Kothandan Gugan, Cho Seung Joo
Primary Institution: Chosun University
Hypothesis
Can the structural modifications of tetrahydroisoquinoline-ethyl-phenylamine compounds enhance their effectiveness as P-glycoprotein modulators?
Conclusion
The study identified key structural features that enhance the inhibitory potency of new P-glycoprotein modulators.
Supporting Evidence
- The Topomer CoMFA model showed a high correlation coefficient (r2 = 0.975) indicating good predictive ability.
- The HQSAR model achieved a q2 value of 0.777, demonstrating its effectiveness in predicting compound activity.
- Structural analysis revealed that bulky and polar groups at specific positions enhance inhibitory effects.
Takeaway
This study looks at how changing the structure of certain compounds can make them better at fighting cancer by overcoming drug resistance.
Methodology
The study used Topomer CoMFA and HQSAR models to analyze the activity of 39 compounds and predict their effectiveness.
Limitations
The study is limited to in silico models and may not fully capture the complexities of biological systems.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website